NEW: Novavax says Indonesia has given the world's first emergency use authorization for its Covid-19 vaccine, which uses a different technology than currently used shots.
NBC News appThe emergency authorization of the vaccine is a “very important step” for Indonesia's Covid-19 vaccination program, Indonesian epidemiologist Dicky Budiman said.
Budiman said if the rollout of the vaccine is successful, it could lead to its approval and use in other developing nations.In June, U.S.-based Novavax announced the vaccine hadagainst symptomatic Covid-19 in a study of nearly 30,000 people in the U.S. and Mexico. It also worked against variants circulating in those countries at the time, it said.
In October, it addressed concerns that production of the vaccine had been slowed due to a lack of raw materials and other issues, saying it planned to “achieve a capacity of 150 million doses per month by the end of the fourth quarter” through partnerships withNovavax said it has already filed for authorization of the vaccine in the United Kingdom, European Union, Canada, Australia, India and the Philippines.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Novavax Covid-19 Vaccine Gets First Emergency Authorization In Indonesia—Here’s What You Need To KnowI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Leer más »
Novavax COVID-19 vaccine receives first emergency use authorizationNovavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their COVID-19 vaccine in Indonesia, making it the first approval anywhere in the world for Novavax.
Leer más »
Vaccine Custody Wars: Update Part TwoThere are custody disputes occurring between parents all over the country regarding parents’ differences on whether or not to vaccinate their child with the COVID-19 vaccine.
Leer más »
How much is Big Pharma making from COVID-19 vaccines? We're about to find outEarnings Watch: U.S. pharmaceutical companies are expected to collect more revenue from COVID-19 vaccines in the third quarter than they did in the entire first half of the year.
Leer más »
Large U.S. companies to be required to provide paid time off for COVID-19 vaccinations, recoveryOSHA's proposed policy will require companies to provide their employees with paid time off to receive a COVID-19 vaccine and recover from vaccine side effects.
Leer más »
Moderna says FDA needs more time to review its Covid vaccine for teensModerna said the FDA needs more time to complete its review of its Covid-19 vaccine for 12-to-17-year-olds before granting emergency use authorization.
Leer más »